US45166A1025
US45166A1025
IDEAYA Biosciences, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 3.48B EUR | 3.59B EUR | 2.93B EUR | 3.04B EUR |
Enterprise Value | 2.68B EUR | 3.35B EUR | 2.8B EUR | 2.95B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -9.01x | -- | -- | -- |
Price to Sales | 14.88x | 15.34x | 12.99x | 13.88x |
Price to Book | 2.9x | 3x | 3.12x | 2.97x |
EV/Revenue | 11.45x | 14.3x | 12.42x | 13.49x |
EV/EBITDA | -12.51x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -2.03% | -3.15% | -2.98% | -2.4% |